MOTS-C

MOTS-C (Mitochondrial peptide)5 mg

MOTS-C is a mitochondrial signaling peptide that regulates metabolism and stress response. It increases AMPK activation, improves glucose utilization, and enhances fat oxidation. It also helps improve mitochondrial efficiency and insulin sensitivity.

Prescription-led preparation
Availability and formulation are confirmed by the pharmacy after professional review.

ABOUT THIS PREPARATION

A considered approach to personalized care

01Personalized preparationPrepared around the prescription and patient need.
02Pharmacy-led careProfessional guidance from the RevitaLife team.
03Made with care in DubaiA considered compounding experience from enquiry onward.

Product overview

Everything you need to know

Explore the preparation, dosage, clinical information, precautions, storage guidance and references held in this product record.

01Overview

MOTS-C is a mitochondrial signaling peptide that regulates metabolism and stress response.
It increases AMPK activation, improves glucose utilization, and enhances fat oxidation.
It also helps improve mitochondrial efficiency and insulin sensitivity.

02Uses / Indications
  • Insulin resistance / Metabolic syndrome
  • Fatigue and low energy
  • Weight management support
  • Age-related metabolic decline
  • Athletic endurance optimizatio
03Benefits
  • Enhances cellular energy metabolism
  • Improves insulin sensitivity and glucose uptake
  • Supports fat loss and lean body mass
  • Boosts mitochondrial biogenesis and endurance
  • May promote longevity and metabolic health

Dosage Protocol:

  • Injection Route: Subcutaneous (abdomen or thigh)
  • Dose Range: 5–10 mg total per week
    → Common schedule: 5 mg twice weekly (e.g., Monday & Thursday)
  • Cycle Duration: 4–8 weeks
    → May repeat after 2–4 weeks off

Timing:

  • Best injected in the morning (fasted state) or before exercise to optimize mitochondrial activation.
04Side Effects
 

Contraindications / Cautions

Condition Reason / Concern
Pregnancy or breastfeeding No safety data available
Children or adolescents Not studied in minors
Active cancer or neoplasm Possible effects on cellular metabolism — avoid use
Severe liver or kidney disease Altered peptide clearance
Autoimmune disorders May alter immune/metabolic regulation
Concurrent insulin or oral hypoglycemics Risk of additive hypoglycemia
Related topics
compounded productcompounding pharmacymots-cpeptidepeptide protocolprescription support

Professional guidance

Start with the prescription, not the product.

Compounded preparations are supplied only when clinically appropriate and supported by a valid prescription. Product information is educational and does not replace advice from a licensed healthcare professional.

Upload prescription
EXPLORE MORE

Related preparations

Other RevitaLife preparations from the same category.